U. S. Supreme Court-Risperdal $70 Million Verdict

The United States Supreme Court on May 17, 2021 denied certiorari, that is denied review of the $70 million verdict against Janssen, a Johnson & Johnson unit for Pennsylvania male who grew enlarged breast due to taking Risperdal.

Janssen Pharmaceuticals Inc. et al. v. A.Y. et al., # 20-1069, Supreme Court of the United States.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s